Ask AI
ProCE Banner Activity

Closing the Gap in sHTG and FCS: From Differentiation to Targeted Therapy

Clinical Thought

In addressing your frequently asked questions, an endocrinology expert shares his tips and tricks for recognizing severe hypertriglyceridemia (sHTG) vs familial chylomicronemia syndrome (FCS) and applying key therapeutic strategies in patients with sHTG and FCS.

Released: June 26, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Target Audience

This activity is intended for endocrinology physicians, nurse practitioners, and physician associates and other healthcare professionals involved in the care of patients with sHTG, including FCS.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate current and emerging treatment strategies for severe hypertriglyceridemia and FCS to guide individualized patient management